Listed by the USPTO as SPANGLER, JOSEPH RANKIN
Tech Center 1600 • Art Units: 1656
This examiner grants 41% of resolved cases
SPANGLER, JOSEPH RANKIN works in tech center 1600 and art unit 1656. The profile contains 71 resolved cases, an allowance rate of 40.8%, and a median of 1347 days to allowance. The limited case volume warrants caution, but the allowance rate indicates a challenging prosecution record and the median timing points to an extended path to allowance.
The interview lift is 70.6%, the most prominent feature of the available profile, supporting serious consideration of interview-centered prosecution planning. Inbiose N V, Bristol-Myers Squibb Company, and National Institute of Advanced Industrial Science and Technology are the leading companies. The principal firms are Meunier Carlin & Curfman LLC, TRASKBRITT, P.C., and ARENTFOX SCHIFF LLP.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17613904 | METHODS OF MONITORING CELL CULTURE MEDIA | Non-Final OA | Bristol-Myers Squibb Company |
| 17609841 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYHEXANEDIOIC ACID, (E)-HEX-2-ENEDIOIC ACID AND/OR HEXANEDIOIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICALS | Non-Final OA | TORAY INDUSTRIES, INC. |
| 18197579 | BIOANALYSIS OF THERAPEUTIC ANTIBODIES AND RELATED PRODUCTS USING IMMUNOPRECIPITATION AND NATIVE SEC-PCD-MS DETECTION | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18032105 | WW-DOMAIN-ACTIVATED EXTRACELLULAR VESICLES | Final Rejection | President and Fellows of Harvard College |
| 17622020 | Self-Contained Responsive Biological Systems and Methods | Non-Final OA | Arizona Board of Regents on Behalf of the University of Arizona |
| 18558943 | SEQUENCE-DEFINED POLYMERS WITH ONE OR MORE AZIDES, METHODS OF MAKING, AND METHODS OF USE THEREOF | Non-Final OA | Yale University |
| 18863697 | GENETICALLY MODIFIED YEAST AND FERMENTATION PROCESSES FOR THE PRODUCTION OF XYLITOL | Non-Final OA | Cargill, Incorporated |
| 18286324 | ENZYMES, MICRO-ORGANISMS AND USES THEREOF, AND A METHOD OF DEGRADING A POLYOLEFIN | Final Rejection | TEKNOLOGIAN TUTKIMUSKESKUS VTT OY |
| 19048825 | FLAVONOID GLYCOSIDE GLYCOSYLTRANSFERASE LbUGT71BX1 IN LAPORTEA BULBIFERA AS WELL AS THE CODING GENE AND THE USE THEREOF | Non-Final OA | INSTITUTE OF CHINESE MATERIA MEDICA CHINA ACADEMY OF CHINESE MEDICAL SCIENCES |
| 17624764 | METHODS FOR DIAGNOSING MULTIPLE SCLEROSIS | Final Rejection | OXFORD UNIVERSITY INNOVATION LIMITED |
| 18287386 | REAGENT COMPOSITION AND KIT | Final Rejection | DENKA COMPANY LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy40.8% of resolved applications examined by Joseph Rankin Spangler were allowed (71 resolved cases), compared with 44.5% across Art Unit 1656 over the last five years.
This examiner's interview lift is +70.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Joseph Rankin Spangler took 1,347 days on average from filing to allowance.
Joseph Rankin Spangler examines applications in Art Unit 1656 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
